About
Vaccines
CDC recommends that all people aged 6 months and older stay up to date on COVID-19 vaccines and receive a seasonal flu vaccine. If you are 60 years and older, talk to your healthcare provider to see if RSV vaccination is right for you. CDC also recommends nirsevimab, a monoclonal antibody product, for all infants younger than 8 months who are born during – or entering – their first RSV season, as well as some older babies.
More information
Weekly Cumulative Percent Vaccinated in the United States
Cumulative percent of adults vaccinated with COVID-19 (18+ years), influenza (18+ years), or RSV (60+ years) vaccine. Refer to data notes for more details.
Vaccination Status and Intent in the United States
Weekly intent for vaccination and cumulative percent of adults vaccinated with COVID-19 (18+ years), influenza (18+ years), or RSV (60+ years) vaccine. Refer to data notes for more details.
Data Notes
- Source: National Immunization Survey-Adult COVID Module (NIS-ACM), National Immunization Survey-Child COVID Module (NIS-CCM), and National Immunization Survey-Flu (NIS-Flu).
- Additional information available at: About the National Immunization Surveys.
- Note: The NIS-ACM adult data shown for the week ending March 31, 2024 includes the additional day of data collected on March 31, 2024, due to questionnaire changes that went into effect April 1, 2024. The data shown for the week ending June 30, 2024, includes the additional day of data collected on June 30, 2024, due to questionnaire changes that went into effect on July 1, 2024.
- Vaccination coverage estimates are based on all interviews through the current week and represent approximately the cumulative percent vaccinated by mid-week. Each week, estimates for prior weeks are recalculated using the additional interviews conducted that week (combined with all previous interviews).
- Estimates for vaccination intent are based on interviews conducted that week and are adjusted to the cumulative vaccination coverage estimate for that week.
- Confidence Intervals (CI) describe the level of uncertainty around an estimate because a sample was taken via a survey. 95% CIs represent the range of values that would result if the data collection had been repeated many times. For a 95% CI, if the sampling method is repeated many times, the value would fall within this interval at least 95% of the time. Wider CIs reflect larger random error in estimates resulting from survey sampling.
- COVID-19 vaccination coverage estimates presented in this report represent uptake or intent for uptake of the updated 2023-2024 COVID-19 vaccine; uptake of the bivalent or other historic COVID-19 vaccination types are not included in estimates.
- Estimates from the NIS-ACM, NIS-CCM, and NIS-Flu may differ from estimates based on other data sources, and are subject to errors resulting from incomplete sample frame (exclusion of households without cell phones), selection bias (survey respondents may be more likely to be vaccinated than non-respondents), and errors in self or parental reported vaccination status. Estimates are weighted to selected sociodemographic characteristics of the U.S. population to reduce possible bias from incomplete sample frame and selection bias.